This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Kristoffer Rigbolt, PhD
Chief Technology Officer at Gubra

Profile

Kristoffer Rigbolt is chief technology officer of Gubra. He started his career in the omics sciences and was awarded a PhD from University of Southern Denmark in 2011, followed by post-doc in Freiburg Germany. In 2014 Kristoffer moved to Gubra to work as a Bioinformation, but gradually transitioned to working with peptide-based drug discovery and is one of the main contributors to the development of the streaMLine platform for fast drug discovery. Kristoffer specialises in the interface between experimental assays, software development and machine learning/artificial intelligence-based data analysis and has been involved in maturing several drug candidates for clinical trials

Agenda Sessions

  • The streaMLine Platform for Accelerated Peptide Clinical Candidate Identification

    08:45